Review

Published on 10 Jun 2024

Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities

in Cardiovascular Pharmacology and Drug Discovery

Joseph Wayne M. Fowler
LouJin Song
Kelly Tam
Rachel J. Roth Flach

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1412857

2,023 views

Review

Published on 03 Jun 2024

An overview of the treatments for hypertrophic cardiomyopathy

in Cardiovascular Pharmacology and Drug Discovery

Wenna Xu
Fuyu Zhu
Yue Zhang
Peng Li
Yanhui Sheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1387596

2,553 views

Systematic Review

Published on 30 May 2024

The role of tolvaptan add-on therapy in patients with acute heart failure: a systematic review and network meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Vireza Pratama
Jordan Budiono
Jarir At Thobari
Bambang Widyantoro
Vita Yanti Anggraeni
Lucia Kris Dinarti

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1367442

1,912 views
1 citation

Systematic Review

Published on 23 May 2024

Effects of different sodium–glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a network meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Xiaohua Lan
Huijing Zhu
Yanjie Cao
Yue Hu
Xingman Fan
Kaijie Zhang
Mengdi Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1379765

1,995 views
2 citations

Editorial

Published on 20 May 2024

Editorial: Sex differences and cardiovascular therapeutics

in Cardiovascular Pharmacology and Drug Discovery

Fatma Saaoud
Keman Xu
Yifan Lu
Ying Shao
Xiaohua Jiang
Hong Wang
Xiaofeng Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1420293

851 views

Original Research

Published on 13 May 2024

A real-world pharmacovigilance study of drug-induced QT interval prolongation: analysis of spontaneous reports submitted to FAERS

in Cardiovascular Pharmacology and Drug Discovery

Haowen Tan
Xida Yan
Ying Chen
Guili Huang
Luping Luo
Wenjun Li
Weiwei Lan
Cheng Chen
Xin Xi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1363382

2,126 views
1 citation

Review

Published on 09 May 2024

The role of lymphatic endothelial cell metabolism in lymphangiogenesis and disease

in Cardiovascular Pharmacology and Drug Discovery

Summer Simeroth
Pengchun Yu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1392816

1,874 views

Brief Research Report

Published on 30 Apr 2024

Serum concentrations of levosimendan and its metabolites OR-1855 and OR-1896 in cardiac surgery patients with cardiopulmonary bypass

in Cardiovascular Pharmacology and Drug Discovery

Hannah Kipka
Uwe Liebchen
Max Hübner
Georg Höfner
Otto Frey
Klaus T. Wanner
Erich Kilger
Christian Hagl
Roland Tomasi
Hanna Mannell

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1406338

570 views

Original Research

Published on 25 Apr 2024

SGLT2 inhibition, plasma proteins, and heart failure: a proteome-wide Mendelian Randomization and colocalization study

in Cardiovascular Pharmacology and Drug Discovery

Jinlan Luo
Lili Shi
Jingrui Liu
Gen Li
Ling Tu
Shuiqing Hu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1371513

2,993 views

Review

Published on 23 Apr 2024

Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives

in Cardiovascular Pharmacology and Drug Discovery

Liuli Guo
Zhihua Yang
Wenshuai Feng
Yiman Liu
Zhenzhen Li
Pengwei Zhuang
Ming Ren

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1369642

1,038 views

Review

Published on 18 Apr 2024

Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation

in Cardiovascular Pharmacology and Drug Discovery

Yan Zhang
Xue-Ying Zhang
Shan-Rui Shi
Chao-Nan Ma
Yun-Peng Lin
Wen-Gang Song
Shou-Dong Guo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1372055

2,194 views
3 citations

Review

Published on 19 Mar 2024

Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future

in Cardiovascular Pharmacology and Drug Discovery

Shujing Zhou
Ying Liu
Xufeng Huang
Chuhan Wu
Róbert Pórszász

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1337154

6,348 views
2 citations

Mini Review

Published on 13 Mar 2024

Effect of statin add-on therapy on cardiovascular mortality

in Cardiovascular Pharmacology and Drug Discovery

John R. Nelson
Viet Le
Jeffrey L. Anderson
Nicole Ciffone

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1308695

2,686 views

Review

Published on 01 Mar 2024

Silicon in prevention of atherosclerosis and other age-related diseases

in Cardiovascular Pharmacology and Drug Discovery

Łukasz Dudek
Wacław Kochman
Ewelina Dziedzic

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1370536

5,965 views
1 citation

Review

Published on 23 Feb 2024

Data sources and applied methods for paclitaxel safety signal discernment

in Cardiovascular Pharmacology and Drug Discovery

Laura Elisabeth Gressler
Erika Avila-Tang
Jialin Mao
Alejandra Avalos-Pacheco
Fadia T. Shaya
Yelizaveta Torosyan
Alexander Liebeskind
Madris Kinard
Christina D. Mack
Sharon-Lise Normand

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1331142

1,923 views

Original Research

Published on 14 Feb 2024

Anti-hypertensive effect of a novel angiotensin II receptor neprilysin inhibitor (ARNi) -S086 in DSS rat model

in Cardiovascular Pharmacology and Drug Discovery

Jingchao Sun
Ying Xiao
Wenjie Xu
Wei Xing
Frank Du
Maozhi Tian
Danqi Xu
Yihua Ren
Xin Fang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1348897

2,624 views
1 citation

Navigation group

Articles

Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities

An overview of the treatments for hypertrophic cardiomyopathy

The role of tolvaptan add-on therapy in patients with acute heart failure: a systematic review and network meta-analysis

Effects of different sodium–glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a network meta-analysis

Editorial: Sex differences and cardiovascular therapeutics

A real-world pharmacovigilance study of drug-induced QT interval prolongation: analysis of spontaneous reports submitted to FAERS

The role of lymphatic endothelial cell metabolism in lymphangiogenesis and disease

Serum concentrations of levosimendan and its metabolites OR-1855 and OR-1896 in cardiac surgery patients with cardiopulmonary bypass

SGLT2 inhibition, plasma proteins, and heart failure: a proteome-wide Mendelian Randomization and colocalization study

Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives

Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation

Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future

Effect of statin add-on therapy on cardiovascular mortality

Silicon in prevention of atherosclerosis and other age-related diseases

Data sources and applied methods for paclitaxel safety signal discernment

Anti-hypertensive effect of a novel angiotensin II receptor neprilysin inhibitor (ARNi) -S086 in DSS rat model